Latest News

Dr.-Fernando-Pagan
Georgetown Announces Phase II Clinical Trial of Nilotinib for Parkinson’s Disease

Scott Turner, MD, PhD
Georgetown Clinical Trial Testing Nilotinib in Alzheimer’s Disease Begins



Tags : mguh ,

Study Tests New Breast Cancer Drug in African American Women
 The first clinical trial to test a newly approved breast cancer drug specifically in African American patients is now enrolling at Georgetown Lombardi Comprehensive Cancer Center and will begin soon at five other institutions in Washington, DC, Maryland, Alabama and New Jersey.

Precision Medicine Clinical Trial for Metastatic Pancreatic Cancer Now Open at Georgetown Lombardi
 The first clinical trial to compare standard of care chemotherapy with molecularly tailored therapy (also known as precision medicine) for metastatic pancreatic cancer is now enrolling patients at Georgetown Lombardi Comprehensive Cancer Center.